HTL14242
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-W062697-5MG | 5 mg | 456,00 | Add | |
| HY-W062697-10MMO | 10mM/1mL | 501,00 | Add | |
| HY-W062697-10MG | 10 mg | 621,00 | Add | |
| HY-W062697-25MG | 25 mg | 1'407,00 | Add | |
| HY-W062697-50MG | 50 mg | 2'167,00 | Add | |
| HY-W062697-100MG | 100 mg | 3'181,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
HTL14242 (HTL0014242) is an advanced and orally active mGlu5 NAM with a pKi and a pIC50 of 9.3 and 9.2, respectively[1]. HTL14242 can be used for the research of parkinson’s disease[2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, GPCR/G Protein,Neuronal Signaling |
| Format | Solubility: DMSO : 12.5 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 1 |
| Purity | 98.58% |
| Molecular Formula | C16H8ClFN4 |
| Molecular Weight | 310.71 |
| CAS-Number | 1644645-32-8 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
